|
124 Companies |
|
161 Products |
|
161 Products |
|
116 Mechanisms of Action |
|
11 Trials |
|
2428 News |
|
| «12...2324252627282930313233...4950» |
- ||||||| didanosine / Generic mfg.
Trial completion: Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI) (clinicaltrials.gov) - Feb 19, 2014
P3, N=120, Completed, Sponsor: Bristol-Myers Squibb
No longer recruiting --> Completed
- stavudine / Generic mfg., didanosine / Generic mfg.
Trial completion, Combination therapy: A Comparison of Two Dose Levels of Didanosine Used in Combination With Stavudine in HIV-Infected Patients (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=0, Completed, Sponsor: Bristol-Myers Squibb
No longer recruiting --> Completed No longer recruiting --> Completed
- Viracept (nelfinavir) / ViiV Healthcare, Roche
Trial completion: A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=0, Completed, Sponsor: Bristol-Myers Squibb
No longer recruiting --> Completed No longer recruiting --> Completed
- Viracept (nelfinavir) / ViiV Healthcare, Roche
Trial completion: A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV Infection (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=0, Completed, Sponsor: Bristol-Myers Squibb
No longer recruiting --> Completed No longer recruiting --> Completed
- ||| Crixivan (indinavir sulfate) / Merck (MSD)
Trial completion: A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=200, Completed, Sponsor: Bristol-Myers Squibb
No longer recruiting --> Completed No longer recruiting --> Completed
- megestrol / Generic mfg.
Trial completion: A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia (clinicaltrials.gov) - Feb 19, 2014
P3, N=0, Completed, Sponsor: Bristol-Myers Squibb
No longer recruiting --> Completed No longer recruiting --> Completed
- NN1213 / Novo Nordisk
Trial completion: Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=0, Completed, Sponsor: Bristol-Myers Squibb
No longer recruiting --> Completed No longer recruiting --> Completed
- NN1213 / Novo Nordisk
Trial completion, Biopsy: Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised Patients (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=0, Completed, Sponsor: Bristol-Myers Squibb
No longer recruiting --> Completed No longer recruiting --> Completed
- didanosine / Generic mfg., zidovudine / Generic mfg.
Trial completion: A Treatment IND (Investigational New Drug) Protocol for the Use of Videx (2',3'-Dideoxyinosine, ddI) in Patients With Acquired Immunodeficiency Syndrome (AIDS) or AIDS- Related Complex (ARC) Who Are Intolerant to Zidovudine (Retrovir) (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=0, Completed, Sponsor: Bristol-Myers Squibb
No longer recruiting --> Completed No longer recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Observation of HIV-Infected Children Receiving Protease Inhibitor and Reverse Transcriptase Inhibitor (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=50, Completed, Sponsor: National Cancer Institute (NCI)
No longer recruiting --> Completed No longer recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Frequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in Japan (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=3400, Completed, Sponsor: National Institutes of Health Clinical Center (CC)
No longer recruiting --> Completed Recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Study of Patients With Strongyloides Stercoralis Infection (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=650, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Completed Recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Effects of HIV on the Development and Function of Bone Marrow Cells (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=300, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Completed Recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: A Study of Patients With AIDS Syndrome (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=5000, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Completed No longer recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: HIV Levels in Cerebrospinal Fluid and Brain Function in Patients Receiving Anti-HIV Drugs (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=100, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
No longer recruiting --> Completed No longer recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: A Phase I Safety and Immunogenicity Trial of the Facilitated HIV-1 Gag-Pol DNA Vaccine (APL-400-047, Apollon, Inc.) Given Intramuscularly by Needle and Syringe or Biojector 2000 Needle-Free Jet Injection System in HIV-1 Uninfected Adult Volunteers (clinicaltrials.gov) - Feb 19, 2014
P1, N=40, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
No longer recruiting --> Completed No longer recruiting --> Completed
- | adefovir dipivoxil / Generic mfg.
Trial completion: The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected Patients (clinicaltrials.gov) - Feb 19, 2014
P3, N=505, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
No longer recruiting --> Completed Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: A Study on the Rate of Opportunistic (AIDS-Related) Infections Among HIV-Positive Children Who Have Stopped Taking Their OI Preventive Medications (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=200, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed No longer recruiting --> Completed
- | Neutrexin (trimetrexate) / Pfizer
Trial completion: A Treatment Protocol for the Use of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia and Serious Intolerance to Approved Therapies (clinicaltrials.gov) - Feb 19, 2014
P3, N=0, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
No longer recruiting --> Completed Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: HIV Prevention Counseling for Men Who Have Sex With Men (clinicaltrials.gov) - Feb 19, 2014
P3, N=4350, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed No longer recruiting --> Completed
- | Proleukin (aldesleukin) / Merck (MSD), Novartis, Iovance Biotherap, Crixivan (indinavir sulfate) / Merck (MSD), NN1213 / Novo Nordisk
Trial completion, Combination therapy: Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328 (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=110, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
No longer recruiting --> Completed Active, not recruiting --> Completed
- | zidovudine / Generic mfg.
Trial completion: A Study to Evaluate the Effects of Different Methods of Birth Control on the Drug Actions of Zidovudine (an Anti-HIV Drug) in HIV-Positive Women and to Compare Zidovudine Metabolism in Men and Women (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=42, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed No longer recruiting --> Completed
- | zidovudine / Generic mfg.
Trial completion: A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT) (clinicaltrials.gov) - Feb 19, 2014
P3, N=1600, Completed, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
No longer recruiting --> Completed Active, not recruiting --> Completed
- | Cytovene (ganciclovir) / Roche
Trial completion: A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis (clinicaltrials.gov) - Feb 19, 2014
P3, N=0, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Enrollment closed: Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients (clinicaltrials.gov) - Feb 19, 2014
P1, N=33, Active, not recruiting, Sponsor: Sangamo Biosciences
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Trial termination: PrOMPT: Prevention of Early Mortality by Presumptive Tuberculosis (TB) Treatment (clinicaltrials.gov) - Feb 13, 2014
P4, N=44, Terminated, Sponsor: Prof JMA Lange
Recruiting --> Active, not recruiting Not yet recruiting --> Terminated; Study was terminated prematurely due to insufficient enrolment.
- Enrollment change: PrOMPT: Prevention of Early Mortality by Presumptive Tuberculosis (TB) Treatment (clinicaltrials.gov) - Feb 13, 2014
P4, N=44, Terminated, Sponsor: Prof JMA Lange
Not yet recruiting --> Terminated; Study was terminated prematurely due to insufficient enrolment. N=334 --> 44
- | Tivicay (dolutegravir) / ViiV Healthcare
New P1 trial: Effect of Dolutegravir on Metformin Pharmacokinetics in Healthy Adult Subjects (clinicaltrials.gov) - Feb 13, 2014
P1, N=30, Active, not recruiting, Sponsor: ViiV Healthcare
- darunavir/ritonavir / Generic mfg., lopinavir/ritonavir / Generic mfg.
Enrollment change, Monotherapy: Clinical Study to Evaluate the Efficacy and Safety of Lopinavir/Ritonavir Monotherapy Versus Darunavir/Ritonavir Monotherapies as Simplification Switching Strategies of PI/NNRTI-Triple Therapy Based-Regimens (clinicaltrials.gov) - Feb 11, 2014
P4, N=73, Completed, Sponsor: Germans Trias i Pujol Hospital
N=334 --> 44 N=102 --> 73
- | New P2 trial: Early Versus Delayed BCG Vaccination of HIV-exposed Infants (clinicaltrials.gov) - Feb 11, 2014
P2, N=151, Completed, Sponsor: University of Cape Town
- darunavir/ritonavir / Generic mfg., lopinavir/ritonavir / Generic mfg.
Trial completion, Monotherapy: Clinical Study to Evaluate the Efficacy and Safety of Lopinavir/Ritonavir Monotherapy Versus Darunavir/Ritonavir Monotherapies as Simplification Switching Strategies of PI/NNRTI-Triple Therapy Based-Regimens (clinicaltrials.gov) - Feb 11, 2014
P4, N=73, Completed, Sponsor: Germans Trias i Pujol Hospital
N=102 --> 73 Active, not recruiting --> Completed
- Trial completion: Use of the Shang Ring Circumcision Device in Boys Below 18 Years Old in Kenya (clinicaltrials.gov) - Feb 10, 2014
P=N/A, N=80, Completed, Sponsor: EngenderHealth
Active, not recruiting --> Completed Not yet recruiting --> Completed
- | Vocabria (cabotegravir oral) / ViiV Healthcare
New P1 trial: A Study to Assess The Relative Bioavailability of New Tablet Formulations of GSK1265744 in Healthy Adult Subjects (clinicaltrials.gov) - Feb 9, 2014
P1, N=24, Recruiting, Sponsor: ViiV Healthcare
- || nevirapine / Generic mfg.
Enrollment closed, Adherence: Observational Study of Nevirapine Extended Release in Human Immunodeficiency Virus (HIV) Patients in Daily Clinical Practice (clinicaltrials.gov) - Feb 4, 2014
P=N/A, N=440, Active, not recruiting, Sponsor: Boehringer Ingelheim
Not yet recruiting --> Completed Recruiting --> Active, not recruiting
- lopinavir/ritonavir / Generic mfg.
Trial completion: Routine Use of Antiretroviral Therapy to Prevent Mother-to-Child HIV Transmission in the Kafue District of Zambia (clinicaltrials.gov) - Feb 4, 2014
P4, N=284, Completed, Sponsor: University of North Carolina, Chapel Hill
Recruiting --> Active, not recruiting Terminated --> Completed
- Trial completion: Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana (clinicaltrials.gov) - Feb 4, 2014
P4, N=2000, Completed, Sponsor: Centers for Disease Control and Prevention
Terminated --> Completed Active, not recruiting --> Completed
- ||||| lamivudine / Generic mfg.
Trial initiation date, Head-to-Head: MOBIDIP: Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa (clinicaltrials.gov) - Feb 3, 2014
P3, N=264, Not yet recruiting, Sponsor: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
Active, not recruiting --> Completed Initiation date: Sep 2013 --> Feb 2014
- | Selzentry (maraviroc) / ViiV Healthcare, Isentress (raltegravir) / Merck (MSD)
Trial completion: OPTIPRIM 2-ANRS: Optimisation of Primary HIV1 Infection Treatment(ANRS 147 OPTIPRIM) (clinicaltrials.gov) - Feb 3, 2014
P3, N=90, Completed, Sponsor: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
Initiation date: Sep 2013 --> Feb 2014 Active, not recruiting --> Completed
- | THV-01 / TheraVectys
New P1/2 trial: Safety, Tolerability and Immunogenicity Induced by the THV01 Treatment in Patients Infected With HIV-1 Clade B and Treated With Highly Active Antiretroviral Therapy (HAART). (clinicaltrials.gov) - Feb 2, 2014
P1/2, N=36, Active, not recruiting, Sponsor: Theravectys S.A.
- | THV-01 / TheraVectys
Enrollment closed: Safety, Tolerability and Immunogenicity Induced by the THV01 Treatment in Patients Infected With HIV-1 Clade B and Treated With Highly Active Antiretroviral Therapy (HAART). (clinicaltrials.gov) - Feb 2, 2014
P1/2, N=36, Active, not recruiting, Sponsor: Theravectys S.A.
Active, not recruiting --> Completed Not yet recruiting --> Active, not recruiting
- Trial initiation date: Lactoferrin Treatment in HIV Patients (clinicaltrials.gov) - Jan 31, 2014
P2, N=50, Suspended, Sponsor: Jason Baker
Not yet recruiting --> Active, not recruiting Initiation date: Oct 2013 --> May 2014
- Vocabria (cabotegravir oral) / ViiV Healthcare
Enrollment open: Study to Evaluate the Effect of GSK1265744 on Cardiac Conduction (clinicaltrials.gov) - Jan 29, 2014
P1, N=42, Recruiting, Sponsor: ViiV Healthcare
Initiation date: Oct 2013 --> May 2014 Not yet recruiting --> Recruiting
- | Isentress (raltegravir) / Merck (MSD)
Trial completion: Comparative Study of Three NNRTI-Sparing HAART Regimens (clinicaltrials.gov) - Jan 27, 2014
P3, N=1813, Completed, Sponsor: AIDS Clinical Trials Group
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- ||||||| Trial completion: Safety and Efficacy of Tenofovir DF in HIV-1 Infected Adolescents Failing Their Current Antiretroviral Therapy (clinicaltrials.gov) - Jan 26, 2014
P3, N=87, Completed, Sponsor: Gilead Sciences
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Enrollment closed: Safety and Immunogenicity Study of SeV-G(NP) HIV Vaccine Administered Intranasally and Ad35-GRIN HIV Vaccine Given Intramuscularly in Prime-Boost Regimens in HIV-Uninfected Volunteers (clinicaltrials.gov) - Jan 22, 2014
P1, N=64, Active, not recruiting, Sponsor: International AIDS Vaccine Initiative
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- |||| Incivek (telaprevir) / J&J, Vertex, Mitsubishi Tanabe
Trial completion: TelapreVIH: Telaprevir in HIV-HCV Coinfected Patients Who Had Previously Failed a Peginterferon-Ribavirin Regimen (clinicaltrials.gov) - Jan 21, 2014
P2, N=70, Completed, Sponsor: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Enrollment change: Treatment for Depression Among HIV-Infected Youth (clinicaltrials.gov) - Jan 20, 2014
P=N/A, N=42, Completed, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Active, not recruiting --> Completed N=56 --> 42
- | AGS-004 / CoImmune
New P1/2 trial: A Phase I Study to Evaluate the Immunologic Response and Virologic Impact of AGS-004 (clinicaltrials.gov) - Jan 20, 2014
P1/2, N=12, Recruiting, Sponsor: Cynthia L Gay, MD
- Enrollment open: PESS: Pediatric Enhanced Surveillance Study (clinicaltrials.gov) - Jan 20, 2014
P=N/A, N=400, Recruiting, Sponsor: Columbia University
N=56 --> 42 Not yet recruiting --> Recruiting
- emtricitabine/tenofovir disoproxil fumarate / Generic mfg.
Enrollment closed: An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis (clinicaltrials.gov) - Jan 20, 2014
P2, N=200, Active, not recruiting, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting